###begin article-title 0
###xml 2 7 <span type="species:ncbi:4932">yeast</span>
A yeast two-hybrid system reconstituting substrate recognition of the von Hippel-Lindau tumor suppressor protein
###end article-title 0
###begin p 1
Present addresses: Claudia Bex, Department of Biological Sciences, Imperial College London, Imperial College Road, London SW7 2AZ, UK.
###end p 1
###begin p 2
Katja Knauth, Institute of Biochemistry, Swiss Federal Institute of Technology Zurich, Schafmattstrasse 18, CH-8093 Zurich, Switzerland.
###end p 2
###begin p 3
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 3
###begin p 4
###xml 227 230 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 539 544 <span type="species:ncbi:4932">yeast</span>
The von Hippel-Lindau tumor suppressor protein (pVHL) is inactivated in the hereditary cancer syndrome von Hippel-Lindau disease and in the majority of sporadic renal carcinomas. pVHL is the substrate-binding subunit of the CBCVHL ubiquitin ligase complex that negatively regulates cell growth by promoting the degradation of hypoxia-inducible transcription factor subunits (HIF1/2alpha). Proteomics-based identification of novel pVHL substrates is hampered by their short half-life and low abundancy in mammalian cells. The usefulness of yeast two-hybrid (Y2H) approaches, on the other hand, has been limited by the failure of pVHL to adopt its native structure and by the absence of prolylhydroxylase activity critical for pVHL substrate recognition. Therefore, we modified the Y2H system to faithfully reconstitute the physical interaction between pVHL and its substrates. Our approach relies on the coexpression of pVHL with the cofactors Elongin B and Elongin C and with HIF1/2alpha prolylhydroxylases. In a proof-of-principle Y2H screen, we identified the known substrates HIF1/2alpha and new candidate substrates including diacylglycerol kinase iota, demonstrating that our strategy allows detection of stable interactions between pVHL and otherwise elusive cellular targets. Additional future applications may include structure/function analyses of pVHL-HIF1/2alpha binding and screens for therapeutically relevant compounds that either stabilize or disrupt this interaction.
###end p 4
###begin title 5
INTRODUCTION
###end title 5
###begin p 6
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 767 770 767 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 800 801 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
###xml 481 486 <span type="species:ncbi:4932">yeast</span>
###xml 758 763 <span type="species:ncbi:9606">human</span>
The yeast two-hybrid (Y2H) system has proved an invaluable tool for the identification of protein-protein interactions, both in standard laboratory screens and in high-throughput automated formats (1,2). However, despite the successful identification of thousands of binding partners from various organisms, the Y2H approach is subject to certain limitations. For example, interactions that critically depend on post-translational modifications by enzymatic activities absent from yeast cannot be detected. Furthermore, subunits of heterooligomeric complexes are likely to adopt non-native conformations in the absence of their natural binding partners, giving rise to biologically irrelevant Y2H interactions. Both potential problems are illustrated by the human CBCVHL E3 ubiquitin ligase complex (3) with its substrate recognition subunit, the von Hippel-Lindau tumor suppressor protein (pVHL).
###end p 6
###begin p 7
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 463 466 455 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4 B5 B6">4&#8211;6</xref>
###xml 665 669 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7 B8 B9 B10">7&#8211;10</xref>
###xml 752 755 732 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 1016 1019 992 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4 B5 B6">4&#8211;6</xref>
###xml 1253 1258 1229 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11 B12 B13">11&#8211;13</xref>
###xml 601 606 <span type="species:ncbi:9606">human</span>
CBCVHL is a heterooligomeric complex comprising the core subunits Cullin-2, Rbx1/Roc1, Elongin B (ELB) and Elongin C (ELC), and the pVHL substrate recognition subunit (3). Key cellular targets of the CBCVHL E3 ubiquitin ligase activity include the alpha subunit of hypoxia-inducible transcription factor 1, HIF1alpha, and its close homolog, HIF2alpha, which are important regulators of angiogenesis, glucose uptake and metabolism, cell growth and the cell cycle (4-6). Recognition of HIF1/2alpha by pVHL requires the post-translational hydroxylation of two conserved prolyl residues (P564 and P402 in human HIF-1alpha) by a new family of prolylhydroxylases (PHDs) (7-10). Under normoxic conditions, HIF1/2alpha is hydroxylated by PHDs, recruited to CBCVHL by pVHL, ubiquitylated and rapidly degraded by the 26S proteasome. Conversely, in a hypoxic cellular environment lacking the PHD substrate, molecular oxygen, HIF1/2alpha is not recognized by pVHL and thus stable, leading to the expression of HIF target genes (4-6). Mutational inactivation of pVHL causes the constitutive expression of HIF target genes even under normoxic conditions, which has been shown to be a key tumorigenic event in the hereditary cancer syndrome von Hippel-Lindau disease (11-13).
###end p 7
###begin p 8
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 444 468 440 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 590 593 586 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 1020 1023 1012 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 1046 1048 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1049 1051 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1138 1141 1130 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 1231 1233 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1234 1236 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1378 1380 1366 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1381 1383 1369 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 444 468 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 1394 1399 <span type="species:ncbi:4932">yeast</span>
The identification of CBCVHL targets other than HIF1/2alpha has proven difficult in the past. Proteomics strategies relying on affinity purification schemes and subsequent mass spectrometric identification are complicated by the potential low abundance and short half-life of candidate proteins in mammalian cells. Y2H screens, in contrast, typically depend much less on the physiological abundance and half-life of interactors. In particular, Saccharomyces cerevisiae does not possess orthologs of Cullin-2, ELB and ELC, so that pVHL substrates are not subject to ubiquitylation by the CBCVHL ubiquitin ligase complex and subsequent proteasomal degradation. Consequently, it should, in principle, be possible to detect stable Y2H interactions of pVHL with substrates such as HIF1/2alpha, which are extremely short-lived and of low abundance in mammalian cells. However, Y2H screens using pVHL as bait are impeded by two major limitations: first, pVHL is unable to adopt its native conformation in the absence of the CBCVHL subunits ELB and ELC (14,15). In contrast, pVHL in the context of the ternary pVHL-ELB-ELC (VCB) subcomplex of CBCVHL possesses its native, stable fold and is amenable to structural and biochemical studies (14,16). In particular, the pVHL-binding site for HIF1/2alpha, and presumably other cellular substrates, is only formed in presence of ELB and ELC (17,18). Second, yeast does not possess PHD homologs, precluding the detection of hydroxyprolyl-mediated Y2H interactions.
###end p 8
###begin p 9
###xml 264 269 <span type="species:ncbi:4932">yeast</span>
Here, we describe a modified Y2H system for the detection of pVHL-substrate interactions that relies on the coexpression of pVHL with the cofactors ELB and ELC and with PHDs. We show that this system is able to faithfully recapitulate HIF1alpha binding to pVHL in yeast. Moreover, we report the identification of the known substrates HIF1/2alpha, along with new candidate substrates, in a proof-of-principle library screen, thus demonstrating the strength of the system in detecting even rare pVHL-substrate interactions.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast strains and media
###end title 11
###begin p 12
###xml 4 17 4 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAT</italic>
###xml 46 47 46 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sup>
###xml 148 151 148 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UAS</sub>
###xml 156 160 156 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TATA</sub>
###xml 177 187 177 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17mers(X3)</sub>
###xml 192 196 192 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TATA</sub>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and</italic>
###xml 49 256 49 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ura3-52, his3-200, lys2-801, ade2-101, trp1-901, leu2-3,112, gal4-542, gal80-538, cyh<sup>r</sup>2, LYS2::GAL1<sub>UAS</sub>-GAL1<sub>TATA</sub>-HIS3, URA3::GAL4<sub>17mers(X3)</sub>-CYC1<sub>TATA</sub>-lacZ) <italic>and</italic> CG1945BC (CG1945, ADE2::YIpDCE1-ElonginB-ElonginC</italic>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 550 555 550 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MET25</sub>
###xml 550 555 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>MET25</sub></italic>
###xml 4 17 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 325 330 <span type="species:ncbi:4932">yeast</span>
###xml 391 396 <span type="species:ncbi:4932">yeast</span>
The S. cerevisiae reporter strains CG1945 (MATa, ura3-52, his3-200, lys2-801, ade2-101, trp1-901, leu2-3,112, gal4-542, gal80-538, cyhr2, LYS2::GAL1UAS-GAL1TATA-HIS3, URA3::GAL417mers(X3)-CYC1TATA-lacZ) and CG1945BC (CG1945, ADE2::YIpDCE1-ElonginB-ElonginC) were described previously (19). Cells were grown in YPD medium (1% yeast extract, 2% peptone and 2% glucose), or in SC medium (0.67% yeast nitrogen base without amino acids, 2% glucose) supplemented with an amino acid mix lacking the indicated amino acids for selection and induction of the PMET25 promoter.
###end p 12
###begin title 13
Plasmids
###end title 13
###begin p 14
###xml 42 49 42 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 845 847 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1153 1161 1133 1141 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1.</label>
###xml 1161 1188 1141 1168 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="15">Plasmids used in this study</p>
###xml 1161 1188 1141 1168 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="15">Plasmids used in this study</p></caption>
###xml 1188 1200 1168 1180 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Plasmid name</th>
###xml 1200 1206 1180 1186 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Vector</th>
###xml 1206 1215 1186 1195 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Insert(s)</th>
###xml 1215 1224 1195 1204 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Reference</th>
###xml 1188 1224 1168 1204 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Plasmid name</th><th rowspan="1" colspan="1">Vector</th><th rowspan="1" colspan="1">Insert(s)</th><th rowspan="1" colspan="1">Reference</th></tr>
###xml 1188 1224 1168 1204 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Plasmid name</th><th rowspan="1" colspan="1">Vector</th><th rowspan="1" colspan="1">Insert(s)</th><th rowspan="1" colspan="1">Reference</th></tr></thead>
###xml 1224 1229 1204 1209 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2</td>
###xml 1229 1234 1209 1214 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2</td>
###xml 1234 1238 1214 1218 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None</td>
###xml 1238 1246 1218 1226 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Clontech</td>
###xml 1224 1246 1204 1226 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">None</td><td rowspan="1" colspan="1">Clontech</td></tr>
###xml 1246 1261 1226 1237 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2-HIF1&#945;</td>
###xml 1261 1266 1237 1242 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2</td>
###xml 1266 1293 1242 1265 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human full-length HIF1&#945;</td>
###xml 1293 1303 1265 1275 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1246 1303 1226 1275 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pACT2-HIF1&#945;</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length HIF1&#945;</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1303 1322 1275 1290 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2-HIF1&#945;PPAG</td>
###xml 1322 1327 1290 1295 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2</td>
###xml 1327 1366 1295 1330 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human full-length HIF1&#945; P402A/P564G</td>
###xml 1366 1376 1330 1340 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1303 1376 1275 1340 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pACT2-HIF1&#945;PPAG</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length HIF1&#945; P402A/P564G</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1376 1395 1340 1356 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2-DGK&#953;1-1065</td>
###xml 1395 1400 1356 1361 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2</td>
###xml 1400 1425 1361 1383 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human full-length DGK&#953;</td>
###xml 1425 1435 1383 1393 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1376 1435 1340 1393 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pACT2-DGK&#953;1-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length DGK&#953;</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1435 1453 1393 1408 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2-DGK&#953;1-878</td>
###xml 1453 1458 1408 1413 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2</td>
###xml 1458 1480 1413 1432 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human DGK&#953; aa 1&#8211;878</td>
###xml 1480 1490 1432 1442 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1435 1490 1393 1442 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pACT2-DGK&#953;1-878</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 1&#8211;878</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1490 1508 1442 1457 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2-DGK&#953;1-667</td>
###xml 1508 1513 1457 1462 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2</td>
###xml 1513 1535 1462 1481 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human DGK&#953; aa 1&#8211;667</td>
###xml 1535 1545 1481 1491 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1490 1545 1442 1491 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pACT2-DGK&#953;1-667</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 1&#8211;667</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1545 1566 1491 1509 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2-DGK&#953;879-1065</td>
###xml 1566 1571 1509 1514 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2</td>
###xml 1571 1596 1514 1536 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human DGK&#953; aa 879&#8211;1065</td>
###xml 1596 1606 1536 1546 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1545 1606 1491 1546 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pACT2-DGK&#953;879-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 879&#8211;1065</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1606 1627 1546 1564 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2-DGK&#953;668-1065</td>
###xml 1627 1632 1564 1569 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2</td>
###xml 1632 1657 1569 1591 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human DGK&#953; aa 668&#8211;1065</td>
###xml 1657 1667 1591 1601 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1606 1667 1546 1601 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pACT2-DGK&#953;668-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 668&#8211;1065</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1667 1690 1601 1621 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2-DGK&#953;1-1065PPAA</td>
###xml 1690 1695 1621 1626 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2</td>
###xml 1695 1732 1626 1660 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human full-length DGK&#953; P147A/P903A</td>
###xml 1732 1742 1660 1670 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1667 1742 1601 1670 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pACT2-DGK&#953;1-1065PPAA</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length DGK&#953; P147A/P903A</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1742 1765 1670 1690 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2-DGK&#953;879-1065PA</td>
###xml 1765 1770 1690 1695 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pACT2</td>
###xml 1770 1807 1695 1729 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human DGK&#953; aa 879&#8211;1065 P147A/P903A</td>
###xml 1807 1817 1729 1739 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1742 1817 1670 1739 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pACT2-DGK&#953;879-1065PA</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 879&#8211;1065 P147A/P903A</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1817 1835 1739 1757 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge-pVHL/empty</td>
###xml 1835 1842 1757 1764 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge</td>
###xml 1842 1870 1764 1792 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td>
###xml 1870 1880 1792 1802 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1817 1880 1739 1802 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pBridge-pVHL/empty</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1880 1897 1802 1819 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge-pVHL/PHD1</td>
###xml 1897 1904 1819 1826 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge</td>
###xml 1904 1932 1826 1854 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td>
###xml 1932 1942 1854 1864 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1880 1942 1802 1864 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pBridge-pVHL/PHD1</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 1942 1942 1864 1864 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1942 1942 1864 1864 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1942 1972 1864 1894 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human full-length PHD1 (MCS 2)</td>
###xml 1972 1972 1894 1894 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1942 1972 1864 1894 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD1 (MCS 2)</td><td rowspan="1" colspan="1"/></tr>
###xml 1972 1989 1894 1911 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge-pVHL/PHD2</td>
###xml 1989 1996 1911 1918 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge</td>
###xml 1996 2024 1918 1946 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td>
###xml 2024 2034 1946 1956 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 1972 2034 1894 1956 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pBridge-pVHL/PHD2</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 2034 2034 1956 1956 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2034 2034 1956 1956 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2034 2063 1956 1981 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human PHD2&#916;76&#8211;177 (MCS 2)</td>
###xml 2063 2063 1981 1981 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2034 2063 1956 1981 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human PHD2&#916;76&#8211;177 (MCS 2)</td><td rowspan="1" colspan="1"/></tr>
###xml 2063 2080 1981 1998 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge-pVHL/PHD3</td>
###xml 2080 2087 1998 2005 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge</td>
###xml 2087 2115 2005 2033 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td>
###xml 2115 2125 2033 2043 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 2063 2125 1981 2043 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pBridge-pVHL/PHD3</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 2125 2125 2043 2043 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2125 2125 2043 2043 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2125 2155 2043 2073 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human full-length PHD3 (MCS 2)</td>
###xml 2155 2155 2073 2073 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2125 2155 2043 2073 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD3 (MCS 2)</td><td rowspan="1" colspan="1"/></tr>
###xml 2155 2173 2073 2091 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge-empty/PHD1</td>
###xml 2173 2180 2091 2098 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge</td>
###xml 2180 2192 2098 2110 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None (MCS 1)</td>
###xml 2192 2202 2110 2120 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 2155 2202 2073 2120 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pBridge-empty/PHD1</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 2202 2202 2120 2120 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2202 2202 2120 2120 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2202 2232 2120 2150 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human full-length PHD1 (MCS 2)</td>
###xml 2232 2232 2150 2150 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2202 2232 2120 2150 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD1 (MCS 2)</td><td rowspan="1" colspan="1"/></tr>
###xml 2232 2250 2150 2168 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge-empty/PHD2</td>
###xml 2250 2257 2168 2175 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge</td>
###xml 2257 2269 2175 2187 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None (MCS 1)</td>
###xml 2269 2279 2187 2197 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 2232 2279 2150 2197 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pBridge-empty/PHD2</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 2279 2279 2197 2197 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2279 2279 2197 2197 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2279 2308 2197 2222 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human PHD2&#916;76&#8211;177 (MCS 2)</td>
###xml 2308 2308 2222 2222 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2279 2308 2197 2222 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human PHD2&#916;76&#8211;177 (MCS 2)</td><td rowspan="1" colspan="1"/></tr>
###xml 2308 2326 2222 2240 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge-empty/PHD3</td>
###xml 2326 2333 2240 2247 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pBridge</td>
###xml 2333 2345 2247 2259 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">None (MCS 1)</td>
###xml 2345 2355 2259 2269 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 2308 2355 2222 2269 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pBridge-empty/PHD3</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 2355 2355 2269 2269 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2355 2355 2269 2269 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2355 2385 2269 2299 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human full-length PHD3 (MCS 2)</td>
###xml 2385 2385 2299 2299 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2355 2385 2269 2299 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD3 (MCS 2)</td><td rowspan="1" colspan="1"/></tr>
###xml 2385 2398 2299 2312 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pCMV2B-pVHL19</td>
###xml 2398 2404 2312 2318 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pCMV2B</td>
###xml 2404 2424 2318 2338 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human pVHL aa 54&#8211;213</td>
###xml 2424 2434 2338 2348 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 2385 2434 2299 2348 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pCMV2B-pVHL19</td><td rowspan="1" colspan="1">pCMV2B</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 2434 2447 2348 2361 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pCMV2B-pVHL30</td>
###xml 2447 2453 2361 2367 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pCMV2B</td>
###xml 2453 2472 2367 2386 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human pVHL aa 1&#8211;213</td>
###xml 2472 2482 2386 2396 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">This study</td>
###xml 2434 2482 2348 2396 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pCMV2B-pVHL30</td><td rowspan="1" colspan="1">pCMV2B</td><td rowspan="1" colspan="1">Human pVHL aa 1&#8211;213</td><td rowspan="1" colspan="1">This study</td></tr>
###xml 2482 2498 2396 2409 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pcDNA-HA-DGK&#953;</td>
###xml 2498 2505 2409 2416 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pCMV-HA</td>
###xml 2505 2530 2416 2438 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Human full length DGK&#953;</td>
###xml 2535 2537 2443 2445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 2530 2537 2438 2445 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Ref. <xref ref-type="bibr" rid="B20">20</xref></td>
###xml 2482 2537 2396 2445 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pcDNA-HA-DGK&#953;</td><td rowspan="1" colspan="1">pCMV-HA</td><td rowspan="1" colspan="1">Human full length DGK&#953;</td><td rowspan="1" colspan="1">Ref. <xref ref-type="bibr" rid="B20">20</xref></td></tr>
###xml 1224 2537 1204 2445 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">None</td><td rowspan="1" colspan="1">Clontech</td></tr><tr><td rowspan="1" colspan="1">pACT2-HIF1&#945;</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length HIF1&#945;</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-HIF1&#945;PPAG</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length HIF1&#945; P402A/P564G</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length DGK&#953;</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-878</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 1&#8211;878</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-667</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 1&#8211;667</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;879-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 879&#8211;1065</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;668-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 668&#8211;1065</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-1065PPAA</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length DGK&#953; P147A/P903A</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;879-1065PA</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 879&#8211;1065 P147A/P903A</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/empty</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/PHD1</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD1 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/PHD2</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human PHD2&#916;76&#8211;177 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/PHD3</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD3 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-empty/PHD1</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD1 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-empty/PHD2</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human PHD2&#916;76&#8211;177 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-empty/PHD3</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD3 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pCMV2B-pVHL19</td><td rowspan="1" colspan="1">pCMV2B</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pCMV2B-pVHL30</td><td rowspan="1" colspan="1">pCMV2B</td><td rowspan="1" colspan="1">Human pVHL aa 1&#8211;213</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pcDNA-HA-DGK&#953;</td><td rowspan="1" colspan="1">pCMV-HA</td><td rowspan="1" colspan="1">Human full length DGK&#953;</td><td rowspan="1" colspan="1">Ref. <xref ref-type="bibr" rid="B20">20</xref></td></tr></tbody>
###xml 1188 2537 1168 2445 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Plasmid name</th><th rowspan="1" colspan="1">Vector</th><th rowspan="1" colspan="1">Insert(s)</th><th rowspan="1" colspan="1">Reference</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">None</td><td rowspan="1" colspan="1">Clontech</td></tr><tr><td rowspan="1" colspan="1">pACT2-HIF1&#945;</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length HIF1&#945;</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-HIF1&#945;PPAG</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length HIF1&#945; P402A/P564G</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length DGK&#953;</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-878</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 1&#8211;878</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-667</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 1&#8211;667</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;879-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 879&#8211;1065</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;668-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 668&#8211;1065</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-1065PPAA</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length DGK&#953; P147A/P903A</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;879-1065PA</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 879&#8211;1065 P147A/P903A</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/empty</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/PHD1</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD1 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/PHD2</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human PHD2&#916;76&#8211;177 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/PHD3</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD3 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-empty/PHD1</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD1 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-empty/PHD2</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human PHD2&#916;76&#8211;177 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-empty/PHD3</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD3 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pCMV2B-pVHL19</td><td rowspan="1" colspan="1">pCMV2B</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pCMV2B-pVHL30</td><td rowspan="1" colspan="1">pCMV2B</td><td rowspan="1" colspan="1">Human pVHL aa 1&#8211;213</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pcDNA-HA-DGK&#953;</td><td rowspan="1" colspan="1">pCMV-HA</td><td rowspan="1" colspan="1">Human full length DGK&#953;</td><td rowspan="1" colspan="1">Ref. <xref ref-type="bibr" rid="B20">20</xref></td></tr></tbody></table>
###xml 2537 2650 2445 2558 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="16">MCS, multiple cloning site; pVHL, von Hippel-Lindau protein; PHD, prolyl hydroxylase; DGK, diacylglycerol kinase.</p>
###xml 2537 2650 2445 2558 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="16">MCS, multiple cloning site; pVHL, von Hippel-Lindau protein; PHD, prolyl hydroxylase; DGK, diacylglycerol kinase.</p></fn>
###xml 2537 2650 2445 2558 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn><p textid="16">MCS, multiple cloning site; pVHL, von Hippel-Lindau protein; PHD, prolyl hydroxylase; DGK, diacylglycerol kinase.</p></fn></table-wrap-foot>
###xml 1153 2650 1133 2558 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1.</label><caption><p textid="15">Plasmids used in this study</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Plasmid name</th><th rowspan="1" colspan="1">Vector</th><th rowspan="1" colspan="1">Insert(s)</th><th rowspan="1" colspan="1">Reference</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">None</td><td rowspan="1" colspan="1">Clontech</td></tr><tr><td rowspan="1" colspan="1">pACT2-HIF1&#945;</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length HIF1&#945;</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-HIF1&#945;PPAG</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length HIF1&#945; P402A/P564G</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length DGK&#953;</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-878</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 1&#8211;878</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-667</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 1&#8211;667</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;879-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 879&#8211;1065</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;668-1065</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 668&#8211;1065</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;1-1065PPAA</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human full-length DGK&#953; P147A/P903A</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pACT2-DGK&#953;879-1065PA</td><td rowspan="1" colspan="1">pACT2</td><td rowspan="1" colspan="1">Human DGK&#953; aa 879&#8211;1065 P147A/P903A</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/empty</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/PHD1</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD1 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/PHD2</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human PHD2&#916;76&#8211;177 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-pVHL/PHD3</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213 (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD3 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-empty/PHD1</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD1 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-empty/PHD2</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human PHD2&#916;76&#8211;177 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pBridge-empty/PHD3</td><td rowspan="1" colspan="1">pBridge</td><td rowspan="1" colspan="1">None (MCS 1)</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Human full-length PHD3 (MCS 2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">pCMV2B-pVHL19</td><td rowspan="1" colspan="1">pCMV2B</td><td rowspan="1" colspan="1">Human pVHL aa 54&#8211;213</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pCMV2B-pVHL30</td><td rowspan="1" colspan="1">pCMV2B</td><td rowspan="1" colspan="1">Human pVHL aa 1&#8211;213</td><td rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1">pcDNA-HA-DGK&#953;</td><td rowspan="1" colspan="1">pCMV-HA</td><td rowspan="1" colspan="1">Human full length DGK&#953;</td><td rowspan="1" colspan="1">Ref. <xref ref-type="bibr" rid="B20">20</xref></td></tr></tbody></table><table-wrap-foot><fn><p textid="16">MCS, multiple cloning site; pVHL, von Hippel-Lindau protein; PHD, prolyl hydroxylase; DGK, diacylglycerol kinase.</p></fn></table-wrap-foot></table-wrap>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 200 205 <span type="species:ncbi:9606">human</span>
###xml 441 446 <span type="species:ncbi:9606">human</span>
###xml 486 491 <span type="species:ncbi:9606">human</span>
###xml 688 693 <span type="species:ncbi:9606">human</span>
Plasmids used in this study are listed in Table 1. Bait plasmids were constructed using standard procedures by cloning the coding sequences for the short isoform of human pVHL (codons 54-213) and for human full-length PHD1, a PHD2 variant lacking residues 76-177 (10), or full-length PHD3 into multiple cloning sites 1 and 2, respectively, of pBridge (Clontech). Prey plasmids were constructed by cloning the coding sequences of full-length human HIF1alpha or full-length and truncated human DGKiota into pACT2 (Clontech). Mammalian pVHL expression plasmids were constructed by cloning the coding sequences for the long (codons 1-213) and short (codons 54-213) isoforms, respectively, of human pVHL into pCMV-Tag2B (Stratagene). Construction details are available from the authors upon request. The mammalian expression plasmid pCMV-HA-DGKiota (20) was a gift of S. Prescott. pACT2-HIF1alphaPPAG, pACT2-DGKiota1-1065PPAA and pACT2-DGKiota879-1065PA were generated by site-directed mutagenesis of the corresponding wild-type plasmids using the QuikChangeXL kit (Stratagene) according to the manufacturer's instructions. All inserts were fully sequenced. Table 1.Plasmids used in this studyPlasmid nameVectorInsert(s)ReferencepACT2pACT2NoneClontechpACT2-HIF1alphapACT2Human full-length HIF1alphaThis studypACT2-HIF1alphaPPAGpACT2Human full-length HIF1alpha P402A/P564GThis studypACT2-DGKiota1-1065pACT2Human full-length DGKiotaThis studypACT2-DGKiota1-878pACT2Human DGKiota aa 1-878This studypACT2-DGKiota1-667pACT2Human DGKiota aa 1-667This studypACT2-DGKiota879-1065pACT2Human DGKiota aa 879-1065This studypACT2-DGKiota668-1065pACT2Human DGKiota aa 668-1065This studypACT2-DGKiota1-1065PPAApACT2Human full-length DGKiota P147A/P903AThis studypACT2-DGKiota879-1065PApACT2Human DGKiota aa 879-1065 P147A/P903AThis studypBridge-pVHL/emptypBridgeHuman pVHL aa 54-213 (MCS 1)This studypBridge-pVHL/PHD1pBridgeHuman pVHL aa 54-213 (MCS 1)This studyHuman full-length PHD1 (MCS 2)pBridge-pVHL/PHD2pBridgeHuman pVHL aa 54-213 (MCS 1)This studyHuman PHD2Delta76-177 (MCS 2)pBridge-pVHL/PHD3pBridgeHuman pVHL aa 54-213 (MCS 1)This studyHuman full-length PHD3 (MCS 2)pBridge-empty/PHD1pBridgeNone (MCS 1)This studyHuman full-length PHD1 (MCS 2)pBridge-empty/PHD2pBridgeNone (MCS 1)This studyHuman PHD2Delta76-177 (MCS 2)pBridge-empty/PHD3pBridgeNone (MCS 1)This studyHuman full-length PHD3 (MCS 2)pCMV2B-pVHL19pCMV2BHuman pVHL aa 54-213This studypCMV2B-pVHL30pCMV2BHuman pVHL aa 1-213This studypcDNA-HA-DGKiotapCMV-HAHuman full length DGKiotaRef. 20MCS, multiple cloning site; pVHL, von Hippel-Lindau protein; PHD, prolyl hydroxylase; DGK, diacylglycerol kinase.
###end p 14
###begin p 15
Plasmids used in this study
###end p 15
###begin p 16
MCS, multiple cloning site; pVHL, von Hippel-Lindau protein; PHD, prolyl hydroxylase; DGK, diacylglycerol kinase.
###end p 16
###begin title 17
Directed two-hybrid interactions
###end title 17
###begin p 18
###xml 195 201 195 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 426 432 426 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600 nm</sub>
###xml 105 110 <span type="species:ncbi:4932">yeast</span>
For the initial characterization of the two-hybrid system and for the verification of screening results, yeast cells were transformed simultaneously with bait and prey plasmids according to Knop et al. (21) and plated onto plates lacking leucine, tryptophane and methionine (SC-LWM). After 3 days, several transformants were picked with a sterile toothpick and resuspended in sterile water. Cell numbers were adjusted to an OD600 nm of 0.2, and 5 mul of the cell suspension were spotted onto selective plates as indicated. Interactions were evaluated after 3 days.
###end p 18
###begin title 19
Y2H screen
###end title 19
###begin p 20
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 240 241 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 558 559 555 556 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 9 14 <span type="species:ncbi:4932">yeast</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 646 651 <span type="species:ncbi:4932">Yeast</span>
CG1945BC yeast cells carrying the bait plasmid pBridge-pVHL/PHD3 were transformed with a human testis cDNA library in pACT2 (Clontech) according to the protocol for high transformation efficiency by Gietz and Woods (22). A total of 1.5 x 107 transformants were plated onto plates lacking leucine, tryptophane, methionine and histidine (SC-LWMH) and containing 5 mM 3-aminotriazol (3-AT). Colonies appearing after 3 days were replica plated onto SC-LWMH plates containing 5 or 25 mM 3-AT and incubated for 5 days. Subsequently, 5-bromo-4-chloro-3-indoyl beta-d-galactoside (XGal) colony-lift filter assays were performed according to the Clontech Yeast Protocols Handbook. Prey plasmids from colonies growing in the presence of 5 and 25 mM 3-AT and scoring positive in XGal colony-lift filter assays were isolated and re-transformed together with pBridge-pVHL/PHD3 to verify the interaction, or with pBridge-empty/PHD3 to identify auto-activating library plasmids.
###end p 20
###begin title 21
Western blots
###end title 21
###begin p 22
###xml 114 120 114 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600 nm</sub>
###xml 194 200 194 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast patches growing on SC-LWM control plates were picked and dissolved in sterile water, diluted to identical OD600 nm values and further processed for western blot analysis according to Knop et al. (21). Expression levels were detected with antibodies against pVHL (Ig32; Pharmingen), HIF1alpha, PHD1, PHD2, PHD3 (all Novus Biologicals) and Gal4 transactivation domain (sc-1663; Santa Cruz).
###end p 22
###begin title 23
Immunoprecipitation
###end title 23
###begin p 24
###xml 695 696 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1060 1066 <span type="species:ncbi:9986">rabbit</span>
HEK293T cells grown in DMEM, 10% FCS, 100 U/ml penicillin, 100 microg/ml streptomycin in 10 cm cell culture dishes were co-transfected with mammalian expression plasmids pCMV-2B-VHL and pCMV-HA-DGKiota using the calcium phosphate method. Forty-eight hours after transfection, cells were harvested, washed with buffer ECB (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, pH 7.9), and resuspended in lysis buffer (ECB supplemented with 0.25% NP-40, 1 mM DTT, 25 muM MG132, 6 mug/ml antipain, 4.3 mug/ml leupeptin, 4.5 mug/ml aprotinin, 5 mug/ml trypsin inhibitor, 5 mug/ml pepstatin, 6 mug/ml chymostatin, 10 mM NEM). After 15 min incubation on ice, lysates were cleared by centrifugation (15 min, 20 000 g), and the protein concentrations of the supernatants were adjusted with lysis buffer. FLAG-tagged pVHL was immunoprecipitated by overnight incubation with 35 mul of FLAG-M2 beads (Sigma), followed by three wash steps with ECB containing 0.25% NP-40 and 1 mM DTT. Bound proteins were analyzed by western blots using anti-FLAG antibody (M2, Sigma) and a polyclonal rabbit antibody raised in-house against a recombinantly expressed, C-terminal fragment (amino acid residues 748-1065) of DGKiota.
###end p 24
###begin title 25
RESULTS
###end title 25
###begin title 26
Reconstitution of pVHL substrate interactions in a Y2H system
###end title 26
###begin p 27
###xml 229 238 229 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bona fide</italic>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 647 655 647 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 787 795 783 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 841 849 837 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1234 1238 1218 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIS3</italic>
###xml 1243 1247 1227 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 1556 1565 1536 1545 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1640 1641 1620 1621 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 1812 1816 1788 1792 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADH1</sub>
###xml 1926 1931 1902 1907 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MET25</sub>
###xml 2112 2116 2088 2092 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK1</sub>
###xml 2157 2161 2133 2137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADE2</italic>
###xml 2169 2171 2145 2147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 2175 2176 2151 2152 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 1565 2401 1545 2373 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="28">Yeast two-hybrid system for the detection of pVHL&#8211;substrate interactions. (<bold>a</bold>) Essential elements of the system. The BD-pVHL bait and AD-HIF1&#945; prey fusions are expressed from the pBridge and pACT2 vectors under the control of the constitutive P<sub>ADH1</sub> promoter. The pBridge vector in addition allows for the expression of PHD1, 2 or 3 under the control of the P<sub>MET25</sub> promoter, which is induced in the absence of methionine. The yeast reporter strain CG1945BC is a derivative of CG1945 expressing ELB and ELC under the control of the constitutive P<sub>PGK1</sub> promoter from chromosome XV next to the <italic>ADE2</italic> locus (<xref ref-type="bibr" rid="B19">19</xref>). (<bold>b</bold>) Schematic representation of reporter gene activation by the PHD-, ELB-, ELC-dependent interaction between BD-pVHL and AD-HIF1&#945;. Pro, HO-Pro; unmodified and hydroxylated form, respectively, of PHD target prolyl residues.</p>
###xml 1565 2401 1545 2373 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="28">Yeast two-hybrid system for the detection of pVHL&#8211;substrate interactions. (<bold>a</bold>) Essential elements of the system. The BD-pVHL bait and AD-HIF1&#945; prey fusions are expressed from the pBridge and pACT2 vectors under the control of the constitutive P<sub>ADH1</sub> promoter. The pBridge vector in addition allows for the expression of PHD1, 2 or 3 under the control of the P<sub>MET25</sub> promoter, which is induced in the absence of methionine. The yeast reporter strain CG1945BC is a derivative of CG1945 expressing ELB and ELC under the control of the constitutive P<sub>PGK1</sub> promoter from chromosome XV next to the <italic>ADE2</italic> locus (<xref ref-type="bibr" rid="B19">19</xref>). (<bold>b</bold>) Schematic representation of reporter gene activation by the PHD-, ELB-, ELC-dependent interaction between BD-pVHL and AD-HIF1&#945;. Pro, HO-Pro; unmodified and hydroxylated form, respectively, of PHD target prolyl residues.</p></caption>
###xml 2401 2401 2373 2373 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm932f1"/>
###xml 1556 2401 1536 2373 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="28">Yeast two-hybrid system for the detection of pVHL&#8211;substrate interactions. (<bold>a</bold>) Essential elements of the system. The BD-pVHL bait and AD-HIF1&#945; prey fusions are expressed from the pBridge and pACT2 vectors under the control of the constitutive P<sub>ADH1</sub> promoter. The pBridge vector in addition allows for the expression of PHD1, 2 or 3 under the control of the P<sub>MET25</sub> promoter, which is induced in the absence of methionine. The yeast reporter strain CG1945BC is a derivative of CG1945 expressing ELB and ELC under the control of the constitutive P<sub>PGK1</sub> promoter from chromosome XV next to the <italic>ADE2</italic> locus (<xref ref-type="bibr" rid="B19">19</xref>). (<bold>b</bold>) Schematic representation of reporter gene activation by the PHD-, ELB-, ELC-dependent interaction between BD-pVHL and AD-HIF1&#945;. Pro, HO-Pro; unmodified and hydroxylated form, respectively, of PHD target prolyl residues.</p></caption><graphic xlink:href="gkm932f1"/></fig>
###xml 376 381 <span type="species:ncbi:4932">yeast</span>
###xml 635 640 <span type="species:ncbi:9606">human</span>
###xml 1447 1452 <span type="species:ncbi:4932">yeast</span>
###xml 1565 1570 <span type="species:ncbi:4932">Yeast</span>
###xml 1993 1998 <span type="species:ncbi:4932">yeast</span>
Due to serious doubts about the usefulness of free, presumably non-native pVHL as bait in standard Y2H screens, our aim was to establish a system that was able to identify selectively, or at least preferentially, interactors and bona fide substrates of native pVHL in the context of the stable, ternary VCB complex. To that end, we relied on a previously established reporter yeast strain constitutively expressing ELB and ELC, CG1945BC (19). This strain was transformed with a plasmid derived from the pBridge vector that allows simultaneous expression of the bait pVHL fused to the Gal4 DNA-binding domain (BD) with one of the three human PHDs (Figure 1a). To test the functionality of this system, we used a prey plasmid expressing HIF1alpha fused to the Gal4 activation domain (AD) (Figure 1a). According to the rationale of the system (Figure 1b), proline residues 402 and/or 564 of HIF1alpha should be hydroxylated by the PHDs. The prolyl hydroxylation enables pVHL to bind HIF1alpha, provided that pVHL is stabilized in its native conformation by ELB and ELC. This hydroxyprolyl-dependent interaction between bait and prey should direct the quartenary BD-pVHL/ELB/ELC/AD-HIF1alpha complex to Gal4 binding sites upstream of the HIS3 and lacZ reporter genes via the BD fused to pVHL, thus inducing the activation of reporter gene expression by the AD fused to HIF1alpha. The two-hybrid interaction is monitored by the ability of the reporter yeast strain to grow on media lacking histidine, and by the blue staining of colonies in XGal filter assays. Figure 1.Yeast two-hybrid system for the detection of pVHL-substrate interactions. (a) Essential elements of the system. The BD-pVHL bait and AD-HIF1alpha prey fusions are expressed from the pBridge and pACT2 vectors under the control of the constitutive PADH1 promoter. The pBridge vector in addition allows for the expression of PHD1, 2 or 3 under the control of the PMET25 promoter, which is induced in the absence of methionine. The yeast reporter strain CG1945BC is a derivative of CG1945 expressing ELB and ELC under the control of the constitutive PPGK1 promoter from chromosome XV next to the ADE2 locus (19). (b) Schematic representation of reporter gene activation by the PHD-, ELB-, ELC-dependent interaction between BD-pVHL and AD-HIF1alpha. Pro, HO-Pro; unmodified and hydroxylated form, respectively, of PHD target prolyl residues.
###end p 27
###begin p 28
###xml 75 76 75 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 247 251 243 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADH1</sub>
###xml 361 366 357 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MET25</sub>
###xml 547 551 543 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK1</sub>
###xml 592 596 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADE2</italic>
###xml 604 606 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 610 611 606 607 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 428 433 <span type="species:ncbi:4932">yeast</span>
Yeast two-hybrid system for the detection of pVHL-substrate interactions. (a) Essential elements of the system. The BD-pVHL bait and AD-HIF1alpha prey fusions are expressed from the pBridge and pACT2 vectors under the control of the constitutive PADH1 promoter. The pBridge vector in addition allows for the expression of PHD1, 2 or 3 under the control of the PMET25 promoter, which is induced in the absence of methionine. The yeast reporter strain CG1945BC is a derivative of CG1945 expressing ELB and ELC under the control of the constitutive PPGK1 promoter from chromosome XV next to the ADE2 locus (19). (b) Schematic representation of reporter gene activation by the PHD-, ELB-, ELC-dependent interaction between BD-pVHL and AD-HIF1alpha. Pro, HO-Pro; unmodified and hydroxylated form, respectively, of PHD target prolyl residues.
###end p 28
###begin p 29
###xml 149 157 145 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 767 775 751 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 967 976 947 956 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 1033 1036 1009 1012 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</bold>
###xml 1197 1203 1173 1179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600 nm</sub>
###xml 1350 1351 1326 1327 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 1354 1355 1330 1331 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</bold>
###xml 1560 1566 1536 1542 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600 nm</sub>
###xml 976 2154 956 2122 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="30">Yeast two-hybrid interaction between pVHL and HIF1&#945;. <bold>(a)</bold> CG1945BC (+ELB/C) or CG1945 (&#8211;ELB/C) yeast cells transformed with the indicated combinations of bait (pBridge-) and prey (pACT2-) plasmids were diluted to an OD<sub>600 nm</sub> of 0.2 and spotted on SC-Leu-Trp-Met (&#8212;LWM) control plates or SC-Leu-Trp-Met-His (&#8212;LWMH) reporter plates containing 1 mM 3-aminotriazole (3-AT). (<bold>b</bold>)&#8211;(<bold>f</bold>) Expression levels of components of the yeast two-hybrid system. Yeast cells were directly taken from the SC-Leu-Trp-Met control plates shown in (a), dissolved in sterile water and diluted to identical OD<sub>600 nm</sub> values. Protein expression levels were determined by western blots (WB) using antibodies against pVHL (b), HIF1&#945; (c), PHD1 (d), PHD2 (e) and PHD3 (f). Shown are representative sets of samples taken from CG1945BC cells expressing the indicated pBridge (b, d&#8211;f) and pACT2 (c) constructs. Expression levels were independent of the presence of ELB/ELC and of specific combinations of bait and prey plasmids, as tested in random samples obtained from several different yeast colonies on the SC-Leu-Trp-Met control plates (data not shown). In (c), an asterisk indicates the HIF1&#945; band.</p>
###xml 976 2154 956 2122 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="30">Yeast two-hybrid interaction between pVHL and HIF1&#945;. <bold>(a)</bold> CG1945BC (+ELB/C) or CG1945 (&#8211;ELB/C) yeast cells transformed with the indicated combinations of bait (pBridge-) and prey (pACT2-) plasmids were diluted to an OD<sub>600 nm</sub> of 0.2 and spotted on SC-Leu-Trp-Met (&#8212;LWM) control plates or SC-Leu-Trp-Met-His (&#8212;LWMH) reporter plates containing 1 mM 3-aminotriazole (3-AT). (<bold>b</bold>)&#8211;(<bold>f</bold>) Expression levels of components of the yeast two-hybrid system. Yeast cells were directly taken from the SC-Leu-Trp-Met control plates shown in (a), dissolved in sterile water and diluted to identical OD<sub>600 nm</sub> values. Protein expression levels were determined by western blots (WB) using antibodies against pVHL (b), HIF1&#945; (c), PHD1 (d), PHD2 (e) and PHD3 (f). Shown are representative sets of samples taken from CG1945BC cells expressing the indicated pBridge (b, d&#8211;f) and pACT2 (c) constructs. Expression levels were independent of the presence of ELB/ELC and of specific combinations of bait and prey plasmids, as tested in random samples obtained from several different yeast colonies on the SC-Leu-Trp-Met control plates (data not shown). In (c), an asterisk indicates the HIF1&#945; band.</p></caption>
###xml 2154 2154 2122 2122 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm932f2"/>
###xml 967 2154 947 2122 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="30">Yeast two-hybrid interaction between pVHL and HIF1&#945;. <bold>(a)</bold> CG1945BC (+ELB/C) or CG1945 (&#8211;ELB/C) yeast cells transformed with the indicated combinations of bait (pBridge-) and prey (pACT2-) plasmids were diluted to an OD<sub>600 nm</sub> of 0.2 and spotted on SC-Leu-Trp-Met (&#8212;LWM) control plates or SC-Leu-Trp-Met-His (&#8212;LWMH) reporter plates containing 1 mM 3-aminotriazole (3-AT). (<bold>b</bold>)&#8211;(<bold>f</bold>) Expression levels of components of the yeast two-hybrid system. Yeast cells were directly taken from the SC-Leu-Trp-Met control plates shown in (a), dissolved in sterile water and diluted to identical OD<sub>600 nm</sub> values. Protein expression levels were determined by western blots (WB) using antibodies against pVHL (b), HIF1&#945; (c), PHD1 (d), PHD2 (e) and PHD3 (f). Shown are representative sets of samples taken from CG1945BC cells expressing the indicated pBridge (b, d&#8211;f) and pACT2 (c) constructs. Expression levels were independent of the presence of ELB/ELC and of specific combinations of bait and prey plasmids, as tested in random samples obtained from several different yeast colonies on the SC-Leu-Trp-Met control plates (data not shown). In (c), an asterisk indicates the HIF1&#945; band.</p></caption><graphic xlink:href="gkm932f2"/></fig>
###xml 954 959 <span type="species:ncbi:9606">human</span>
###xml 976 981 <span type="species:ncbi:4932">Yeast</span>
###xml 1074 1079 <span type="species:ncbi:4932">yeast</span>
###xml 1396 1401 <span type="species:ncbi:4932">yeast</span>
###xml 1421 1426 <span type="species:ncbi:4932">Yeast</span>
###xml 2035 2040 <span type="species:ncbi:4932">yeast</span>
Using this system, we observed a robust interaction between pVHL and HIF1alpha that was strictly dependent on the presence of one of the three PHDs (Figure 2a). Consistent with this requirement for a PHD, no interaction was detected between pVHL and a HIF1alpha variant lacking the critical PHD target residues Pro402 and Pro564, HIF1alphaPPAG. Furthermore, no interaction could be detected in a control reporter strain lacking ELB and ELC, indicating that the two-hybrid interaction required the native conformation of pVHL in the context of the VCB complex. Importantly, western blot analysis demonstrated that the lack of the two-hybrid interaction in the negative controls was not the consequence of reduced expression levels of pVHL, the PHDs or HIF1alpha PPAG (Figure 2b-f). Together, these results indicate that the observed two-hybrid interaction between pVHL and HIF1alpha faithfully recapitulates the biologically relevant interaction found in human cells. Figure 2.Yeast two-hybrid interaction between pVHL and HIF1alpha. (a) CG1945BC (+ELB/C) or CG1945 (-ELB/C) yeast cells transformed with the indicated combinations of bait (pBridge-) and prey (pACT2-) plasmids were diluted to an OD600 nm of 0.2 and spotted on SC-Leu-Trp-Met (-LWM) control plates or SC-Leu-Trp-Met-His (-LWMH) reporter plates containing 1 mM 3-aminotriazole (3-AT). (b)-(f) Expression levels of components of the yeast two-hybrid system. Yeast cells were directly taken from the SC-Leu-Trp-Met control plates shown in (a), dissolved in sterile water and diluted to identical OD600 nm values. Protein expression levels were determined by western blots (WB) using antibodies against pVHL (b), HIF1alpha (c), PHD1 (d), PHD2 (e) and PHD3 (f). Shown are representative sets of samples taken from CG1945BC cells expressing the indicated pBridge (b, d-f) and pACT2 (c) constructs. Expression levels were independent of the presence of ELB/ELC and of specific combinations of bait and prey plasmids, as tested in random samples obtained from several different yeast colonies on the SC-Leu-Trp-Met control plates (data not shown). In (c), an asterisk indicates the HIF1alpha band.
###end p 29
###begin p 30
###xml 57 60 53 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(a)</bold>
###xml 221 227 217 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600 nm</sub>
###xml 374 375 370 371 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 378 379 374 375 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</bold>
###xml 584 590 580 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600 nm</sub>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 98 103 <span type="species:ncbi:4932">yeast</span>
###xml 420 425 <span type="species:ncbi:4932">yeast</span>
###xml 445 450 <span type="species:ncbi:4932">Yeast</span>
###xml 1059 1064 <span type="species:ncbi:4932">yeast</span>
Yeast two-hybrid interaction between pVHL and HIF1alpha. (a) CG1945BC (+ELB/C) or CG1945 (-ELB/C) yeast cells transformed with the indicated combinations of bait (pBridge-) and prey (pACT2-) plasmids were diluted to an OD600 nm of 0.2 and spotted on SC-Leu-Trp-Met (-LWM) control plates or SC-Leu-Trp-Met-His (-LWMH) reporter plates containing 1 mM 3-aminotriazole (3-AT). (b)-(f) Expression levels of components of the yeast two-hybrid system. Yeast cells were directly taken from the SC-Leu-Trp-Met control plates shown in (a), dissolved in sterile water and diluted to identical OD600 nm values. Protein expression levels were determined by western blots (WB) using antibodies against pVHL (b), HIF1alpha (c), PHD1 (d), PHD2 (e) and PHD3 (f). Shown are representative sets of samples taken from CG1945BC cells expressing the indicated pBridge (b, d-f) and pACT2 (c) constructs. Expression levels were independent of the presence of ELB/ELC and of specific combinations of bait and prey plasmids, as tested in random samples obtained from several different yeast colonies on the SC-Leu-Trp-Met control plates (data not shown). In (c), an asterisk indicates the HIF1alpha band.
###end p 30
###begin title 31
Screening for novel pVHL interactors
###end title 31
###begin p 32
###xml 76 81 72 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23 B24 B25">23&#8211;25</xref>
###xml 156 161 152 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26 B27 B28">26&#8211;28</xref>
###xml 211 214 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 437 438 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 439 440 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 441 443 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 544 546 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 547 549 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 599 602 587 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
While the role of pVHL in the regulation of HIF1/2alpha is well understood (23-25) and a number of novel cellular functions for pVHL have emerged recently (26-28), the search for additional substrates of the CBCVHL ubiquitin ligase complex remains a key objective in elucidating the pathology of von Hippel-Lindau disease. The existence of three differently regulated PHD isoforms exhibiting differential activities towards HIF1/2alpha (7,8,29) and the apparently intact regulation of HIF1/2alpha in some subtypes of von Hippel-Lindau disease (30,31) suggests that additional cellular targets of CBCVHL exist. Our Y2H system should principally be able to identify such targets.
###end p 32
###begin p 33
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 407 408 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1240 1247 1240 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 1594 1601 1582 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 1680 1688 1668 1676 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2.</label>
###xml 1688 1746 1676 1734 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="34">pVHL interactors identified in the yeast two-hybrid screen</p>
###xml 1688 1746 1676 1734 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="34">pVHL interactors identified in the yeast two-hybrid screen</p></caption>
###xml 1746 1750 1734 1738 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Prey</th>
###xml 1772 1773 1760 1761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1772 1773 1760 1761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 1750 1773 1738 1761 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Longest fragment found<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></th>
###xml 1773 1787 1761 1775 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Number of hits</th>
###xml 1803 1804 1791 1792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1803 1804 1791 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF2"><sup>b</sup></xref>
###xml 1787 1804 1775 1792 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PHD3 requirement<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref></th>
###xml 1816 1817 1804 1805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 1816 1817 1804 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF3"><sup>c</sup></xref>
###xml 1804 1817 1792 1805 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">LxxLAP motif<xref ref-type="table-fn" rid="TF3"><sup>c</sup></xref></th>
###xml 1746 1817 1734 1805 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Prey</th><th rowspan="1" colspan="1">Longest fragment found<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></th><th rowspan="1" colspan="1">Number of hits</th><th rowspan="1" colspan="1">PHD3 requirement<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref></th><th rowspan="1" colspan="1">LxxLAP motif<xref ref-type="table-fn" rid="TF3"><sup>c</sup></xref></th></tr>
###xml 1746 1817 1734 1805 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Prey</th><th rowspan="1" colspan="1">Longest fragment found<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></th><th rowspan="1" colspan="1">Number of hits</th><th rowspan="1" colspan="1">PHD3 requirement<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref></th><th rowspan="1" colspan="1">LxxLAP motif<xref ref-type="table-fn" rid="TF3"><sup>c</sup></xref></th></tr></thead>
###xml 1817 1826 1805 1814 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Elongin C</td>
###xml 1826 1839 1814 1827 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 4&#8211;112 (CT)</td>
###xml 1839 1841 1827 1829 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">26</td>
###xml 1841 1843 1829 1831 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No</td>
###xml 1843 1845 1831 1833 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No</td>
###xml 1817 1845 1805 1833 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Elongin C</td><td rowspan="1" colspan="1">aa 4&#8211;112 (CT)</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td></tr>
###xml 1845 1854 1833 1842 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Elongin B</td>
###xml 1854 1867 1842 1855 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 2&#8211;118 (CT)</td>
###xml 1867 1869 1855 1857 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">10</td>
###xml 1869 1871 1857 1859 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No</td>
###xml 1871 1873 1859 1861 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No</td>
###xml 1845 1873 1833 1861 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Elongin B</td><td rowspan="1" colspan="1">aa 2&#8211;118 (CT)</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td></tr>
###xml 1873 1882 1861 1866 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HIF1&#945;</td>
###xml 1882 1893 1866 1877 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 232&#8211;439,</td>
###xml 1893 1894 1877 1878 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">6</td>
###xml 1894 1897 1878 1881 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 1897 1900 1881 1884 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 1873 1900 1861 1884 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HIF1&#945;</td><td rowspan="1" colspan="1">aa 232&#8211;439,</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr>
###xml 1900 1900 1884 1884 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1900 1910 1884 1894 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 537&#8211;777</td>
###xml 1910 1910 1894 1894 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1910 1910 1894 1894 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1910 1910 1894 1894 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1900 1910 1884 1894 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">aa 537&#8211;777</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 1910 1919 1894 1899 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">HIF2&#945;</td>
###xml 1919 1929 1899 1909 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 331&#8211;537</td>
###xml 1929 1930 1909 1910 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1</td>
###xml 1930 1933 1910 1913 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 1933 1936 1913 1916 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 1910 1936 1894 1916 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">HIF2&#945;</td><td rowspan="1" colspan="1">aa 331&#8211;537</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr>
###xml 1936 1943 1916 1920 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">DGK&#953;</td>
###xml 1943 1953 1920 1930 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 668&#8211;910</td>
###xml 1953 1954 1930 1931 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2</td>
###xml 1954 1957 1931 1934 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 1957 1960 1934 1937 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 1936 1960 1916 1937 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">DGK&#953;</td><td rowspan="1" colspan="1">aa 668&#8211;910</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr>
###xml 1960 1965 1937 1942 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">KIF2C</td>
###xml 1965 1975 1942 1952 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 558&#8211;681</td>
###xml 1975 1976 1952 1953 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1</td>
###xml 1976 1979 1953 1956 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 1979 1982 1956 1959 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 1960 1982 1937 1959 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">KIF2C</td><td rowspan="1" colspan="1">aa 558&#8211;681</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr>
###xml 1982 1986 1959 1963 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">THO1</td>
###xml 1986 2001 1963 1978 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 578&#8211;657 (CT)</td>
###xml 2001 2002 1978 1979 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1</td>
###xml 2002 2005 1979 1982 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 2005 2010 1982 1987 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Yes)</td>
###xml 1982 2010 1959 1987 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">THO1</td><td rowspan="1" colspan="1">aa 578&#8211;657 (CT)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">(Yes)</td></tr>
###xml 2010 2019 1987 1996 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Calpain 7</td>
###xml 2019 2029 1996 2006 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 536&#8211;679</td>
###xml 2029 2030 2006 2007 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">8</td>
###xml 2030 2033 2007 2010 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 2033 2038 2010 2015 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(Yes)</td>
###xml 2010 2038 1987 2015 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Calpain 7</td><td rowspan="1" colspan="1">aa 536&#8211;679</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">(Yes)</td></tr>
###xml 2038 2044 2015 2021 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">YY1AP1</td>
###xml 2044 2059 2021 2036 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 604&#8211;739 (CT)</td>
###xml 2059 2061 2036 2038 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">20</td>
###xml 2061 2064 2038 2041 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 2064 2066 2041 2043 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No</td>
###xml 2038 2066 2015 2043 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">YY1AP1</td><td rowspan="1" colspan="1">aa 604&#8211;739 (CT)</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr>
###xml 2066 2079 2043 2056 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">RBP-MS/type 3</td>
###xml 2079 2088 2056 2065 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 23&#8211;201</td>
###xml 2088 2089 2065 2066 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1</td>
###xml 2089 2092 2066 2069 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 2092 2094 2069 2071 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No</td>
###xml 2066 2094 2043 2071 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">RBP-MS/type 3</td><td rowspan="1" colspan="1">aa 23&#8211;201</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr>
###xml 2094 2100 2071 2077 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">RB1CC1</td>
###xml 2100 2117 2077 2094 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 1407&#8211;1594 (CT)</td>
###xml 2117 2118 2094 2095 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1</td>
###xml 2118 2121 2095 2098 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 2121 2123 2098 2100 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No</td>
###xml 2094 2123 2071 2100 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">RB1CC1</td><td rowspan="1" colspan="1">aa 1407&#8211;1594 (CT)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr>
###xml 2123 2129 2100 2106 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">FKBP38</td>
###xml 2129 2138 2106 2115 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">aa 97&#8211;344</td>
###xml 2138 2139 2115 2116 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1</td>
###xml 2139 2142 2116 2119 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Yes</td>
###xml 2142 2144 2119 2121 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">No</td>
###xml 2123 2144 2100 2121 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">FKBP38</td><td rowspan="1" colspan="1">aa 97&#8211;344</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr>
###xml 1817 2144 1805 2121 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">Elongin C</td><td rowspan="1" colspan="1">aa 4&#8211;112 (CT)</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Elongin B</td><td rowspan="1" colspan="1">aa 2&#8211;118 (CT)</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">HIF1&#945;</td><td rowspan="1" colspan="1">aa 232&#8211;439,</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">aa 537&#8211;777</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HIF2&#945;</td><td rowspan="1" colspan="1">aa 331&#8211;537</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">DGK&#953;</td><td rowspan="1" colspan="1">aa 668&#8211;910</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">KIF2C</td><td rowspan="1" colspan="1">aa 558&#8211;681</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">THO1</td><td rowspan="1" colspan="1">aa 578&#8211;657 (CT)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">(Yes)</td></tr><tr><td rowspan="1" colspan="1">Calpain 7</td><td rowspan="1" colspan="1">aa 536&#8211;679</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">(Yes)</td></tr><tr><td rowspan="1" colspan="1">YY1AP1</td><td rowspan="1" colspan="1">aa 604&#8211;739 (CT)</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">RBP-MS/type 3</td><td rowspan="1" colspan="1">aa 23&#8211;201</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">RB1CC1</td><td rowspan="1" colspan="1">aa 1407&#8211;1594 (CT)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">FKBP38</td><td rowspan="1" colspan="1">aa 97&#8211;344</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr></tbody>
###xml 1746 2144 1734 2121 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Prey</th><th rowspan="1" colspan="1">Longest fragment found<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></th><th rowspan="1" colspan="1">Number of hits</th><th rowspan="1" colspan="1">PHD3 requirement<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref></th><th rowspan="1" colspan="1">LxxLAP motif<xref ref-type="table-fn" rid="TF3"><sup>c</sup></xref></th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Elongin C</td><td rowspan="1" colspan="1">aa 4&#8211;112 (CT)</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Elongin B</td><td rowspan="1" colspan="1">aa 2&#8211;118 (CT)</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">HIF1&#945;</td><td rowspan="1" colspan="1">aa 232&#8211;439,</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">aa 537&#8211;777</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HIF2&#945;</td><td rowspan="1" colspan="1">aa 331&#8211;537</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">DGK&#953;</td><td rowspan="1" colspan="1">aa 668&#8211;910</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">KIF2C</td><td rowspan="1" colspan="1">aa 558&#8211;681</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">THO1</td><td rowspan="1" colspan="1">aa 578&#8211;657 (CT)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">(Yes)</td></tr><tr><td rowspan="1" colspan="1">Calpain 7</td><td rowspan="1" colspan="1">aa 536&#8211;679</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">(Yes)</td></tr><tr><td rowspan="1" colspan="1">YY1AP1</td><td rowspan="1" colspan="1">aa 604&#8211;739 (CT)</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">RBP-MS/type 3</td><td rowspan="1" colspan="1">aa 23&#8211;201</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">RB1CC1</td><td rowspan="1" colspan="1">aa 1407&#8211;1594 (CT)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">FKBP38</td><td rowspan="1" colspan="1">aa 97&#8211;344</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr></tbody></table>
###xml 2144 2145 2121 2122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 2144 2590 2121 2567 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="35"><sup>a</sup>Amino acid residues as determined by sequencing of the prey plasmid insert from the 5&#8242; end; (CT), residue number denotes the authentic C-terminus of the protein; otherwise, the second residue number indicates the end of the sequenced region, not the 3&#8242; end of the prey plasmid insert. Because an oligo(dT)-primed cDNA library was used, most inserts include the authentic 3&#8242; end of the coding sequence and some 3&#8242; untranslated region of the cDNA.</p>
###xml 2144 2590 2121 2567 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF1"><p textid="35"><sup>a</sup>Amino acid residues as determined by sequencing of the prey plasmid insert from the 5&#8242; end; (CT), residue number denotes the authentic C-terminus of the protein; otherwise, the second residue number indicates the end of the sequenced region, not the 3&#8242; end of the prey plasmid insert. Because an oligo(dT)-primed cDNA library was used, most inserts include the authentic 3&#8242; end of the coding sequence and some 3&#8242; untranslated region of the cDNA.</p></fn>
###xml 2590 2591 2567 2568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 2590 2666 2567 2643 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="36"><sup>b</sup>As tested by co-transformation of the prey plasmid with pBridge-pVHL/empty.</p>
###xml 2590 2666 2567 2643 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF2"><p textid="36"><sup>b</sup>As tested by co-transformation of the prey plasmid with pBridge-pVHL/empty.</p></fn>
###xml 2666 2667 2643 2644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 2752 2754 2729 2731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 2666 2756 2643 2733 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="37"><sup>c</sup>Brackets indicate presence of divergent motifs that may still be recognized by PHDs (<xref ref-type="bibr" rid="B32">32</xref>).</p>
###xml 2666 2756 2643 2733 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF3"><p textid="37"><sup>c</sup>Brackets indicate presence of divergent motifs that may still be recognized by PHDs (<xref ref-type="bibr" rid="B32">32</xref>).</p></fn>
###xml 2144 2756 2121 2733 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF1"><p textid="35"><sup>a</sup>Amino acid residues as determined by sequencing of the prey plasmid insert from the 5&#8242; end; (CT), residue number denotes the authentic C-terminus of the protein; otherwise, the second residue number indicates the end of the sequenced region, not the 3&#8242; end of the prey plasmid insert. Because an oligo(dT)-primed cDNA library was used, most inserts include the authentic 3&#8242; end of the coding sequence and some 3&#8242; untranslated region of the cDNA.</p></fn><fn id="TF2"><p textid="36"><sup>b</sup>As tested by co-transformation of the prey plasmid with pBridge-pVHL/empty.</p></fn><fn id="TF3"><p textid="37"><sup>c</sup>Brackets indicate presence of divergent motifs that may still be recognized by PHDs (<xref ref-type="bibr" rid="B32">32</xref>).</p></fn></table-wrap-foot>
###xml 1680 2756 1668 2733 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2.</label><caption><p textid="34">pVHL interactors identified in the yeast two-hybrid screen</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Prey</th><th rowspan="1" colspan="1">Longest fragment found<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></th><th rowspan="1" colspan="1">Number of hits</th><th rowspan="1" colspan="1">PHD3 requirement<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref></th><th rowspan="1" colspan="1">LxxLAP motif<xref ref-type="table-fn" rid="TF3"><sup>c</sup></xref></th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Elongin C</td><td rowspan="1" colspan="1">aa 4&#8211;112 (CT)</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">Elongin B</td><td rowspan="1" colspan="1">aa 2&#8211;118 (CT)</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">HIF1&#945;</td><td rowspan="1" colspan="1">aa 232&#8211;439,</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">aa 537&#8211;777</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">HIF2&#945;</td><td rowspan="1" colspan="1">aa 331&#8211;537</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">DGK&#953;</td><td rowspan="1" colspan="1">aa 668&#8211;910</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">KIF2C</td><td rowspan="1" colspan="1">aa 558&#8211;681</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="1" colspan="1">THO1</td><td rowspan="1" colspan="1">aa 578&#8211;657 (CT)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">(Yes)</td></tr><tr><td rowspan="1" colspan="1">Calpain 7</td><td rowspan="1" colspan="1">aa 536&#8211;679</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">(Yes)</td></tr><tr><td rowspan="1" colspan="1">YY1AP1</td><td rowspan="1" colspan="1">aa 604&#8211;739 (CT)</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">RBP-MS/type 3</td><td rowspan="1" colspan="1">aa 23&#8211;201</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">RB1CC1</td><td rowspan="1" colspan="1">aa 1407&#8211;1594 (CT)</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr><tr><td rowspan="1" colspan="1">FKBP38</td><td rowspan="1" colspan="1">aa 97&#8211;344</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">No</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p textid="35"><sup>a</sup>Amino acid residues as determined by sequencing of the prey plasmid insert from the 5&#8242; end; (CT), residue number denotes the authentic C-terminus of the protein; otherwise, the second residue number indicates the end of the sequenced region, not the 3&#8242; end of the prey plasmid insert. Because an oligo(dT)-primed cDNA library was used, most inserts include the authentic 3&#8242; end of the coding sequence and some 3&#8242; untranslated region of the cDNA.</p></fn><fn id="TF2"><p textid="36"><sup>b</sup>As tested by co-transformation of the prey plasmid with pBridge-pVHL/empty.</p></fn><fn id="TF3"><p textid="37"><sup>c</sup>Brackets indicate presence of divergent motifs that may still be recognized by PHDs (<xref ref-type="bibr" rid="B32">32</xref>).</p></fn></table-wrap-foot></table-wrap>
###xml 142 147 <span type="species:ncbi:9606">human</span>
###xml 299 304 <span type="species:ncbi:9606">human</span>
###xml 1723 1728 <span type="species:ncbi:4932">yeast</span>
After having successfully established the system in directed interaction assays, we thus tested its potential by performing a Y2H screen of a human testis cDNA library. We used the pBridge-pVHL/PHD3 bait plasmid because PHD3 appears to possess the least stringent substrate specificity of the three human PHDs (32) and is localized in both nucleus and cytoplasm in mammalian cells (33). We screened 1.5 x 107 transformants on SC-LWMH plates containing 5 mM 3-aminotriazol, replica plated onto plates containing 5 or 25 mM 3-aminotriazol, and performed XGal filter lift assays from these plates. Prey plasmids from colonies growing on 5 and 25 mM 3-aminotriazol and scoring positive in the XGal assay were isolated and re-transformed into the reporter strain either together with the bait plasmid pBridge-pVHL/PHD3 to verify the two-hybrid interaction, or with pBridge-empty/PHD3 to identify bait-independent, auto-activating library plasmids. About 100 true-positive interactors were further tested for two-hybrid interactions in the absence of PHD3 or ELB/ELC, respectively. Among the true-positive interactors, multiple full-length cDNAs of ELC and ELB were identified that mediated a PHD3-independent interaction with pVHL, as expected (Table 2). Importantly, we identified several cDNAs encoding fragments of HIF1alpha and HIF2alpha, thus providing convincing proof-of-principle for the usefulness of our system in Y2H screens. All HIF1/2alpha fragments spanned one of the two critical prolyl residues and mediated an interaction with pVHL that was entirely dependent on PHD3, ELB and ELC (Table 2 and data not shown), again illustrating the unique specificity of the system. Table 2.pVHL interactors identified in the yeast two-hybrid screenPreyLongest fragment foundaNumber of hitsPHD3 requirementbLxxLAP motifcElongin Caa 4-112 (CT)26NoNoElongin Baa 2-118 (CT)10NoNoHIF1alphaaa 232-439,6YesYesaa 537-777HIF2alphaaa 331-5371YesYesDGKiotaaa 668-9102YesYesKIF2Caa 558-6811YesYesTHO1aa 578-657 (CT)1Yes(Yes)Calpain 7aa 536-6798Yes(Yes)YY1AP1aa 604-739 (CT)20YesNoRBP-MS/type 3aa 23-2011YesNoRB1CC1aa 1407-1594 (CT)1YesNoFKBP38aa 97-3441YesNoaAmino acid residues as determined by sequencing of the prey plasmid insert from the 5' end; (CT), residue number denotes the authentic C-terminus of the protein; otherwise, the second residue number indicates the end of the sequenced region, not the 3' end of the prey plasmid insert. Because an oligo(dT)-primed cDNA library was used, most inserts include the authentic 3' end of the coding sequence and some 3' untranslated region of the cDNA.bAs tested by co-transformation of the prey plasmid with pBridge-pVHL/empty.cBrackets indicate presence of divergent motifs that may still be recognized by PHDs (32).
###end p 33
###begin p 34
###xml 35 40 <span type="species:ncbi:4932">yeast</span>
pVHL interactors identified in the yeast two-hybrid screen
###end p 34
###begin p 35
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aAmino acid residues as determined by sequencing of the prey plasmid insert from the 5' end; (CT), residue number denotes the authentic C-terminus of the protein; otherwise, the second residue number indicates the end of the sequenced region, not the 3' end of the prey plasmid insert. Because an oligo(dT)-primed cDNA library was used, most inserts include the authentic 3' end of the coding sequence and some 3' untranslated region of the cDNA.
###end p 35
###begin p 36
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
bAs tested by co-transformation of the prey plasmid with pBridge-pVHL/empty.
###end p 36
###begin p 37
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
cBrackets indicate presence of divergent motifs that may still be recognized by PHDs (32).
###end p 37
###begin p 38
###xml 232 239 228 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
Besides these known interactors, we identified eight new binding partners that interacted with pVHL in a PHD3- and ELB/ELC-dependent manner, some of them possessing variants of the LxxLAP target motif for PHDs found in HIF1/2alpha (Table 2 and data not shown). In summary, the Y2H screen led to the identification of both known and potential novel substrates of pVHL.
###end p 38
###begin title 39
A novel, PHD-dependent two-hybrid interactor of pVHL
###end title 39
###begin p 40
###xml 200 202 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 203 205 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 472 480 463 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 577 585 565 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 591 598 579 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 601 610 589 598 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 610 862 598 836 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="41">DGK&#953; possesses two LxxLAP motifs. Sequence alignments of the N-terminal (top) and C-terminal (bottom) PHD recognition motifs found in HIF1&#945;, HIF2&#945; and DGK&#953;. The LxxLAP consensus motif is underlined, with the target prolyl residue in bold.</p>
###xml 610 862 598 836 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="41">DGK&#953; possesses two LxxLAP motifs. Sequence alignments of the N-terminal (top) and C-terminal (bottom) PHD recognition motifs found in HIF1&#945;, HIF2&#945; and DGK&#953;. The LxxLAP consensus motif is underlined, with the target prolyl residue in bold.</p></caption>
###xml 862 862 836 836 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm932f3"/>
###xml 601 862 589 836 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="41">DGK&#953; possesses two LxxLAP motifs. Sequence alignments of the N-terminal (top) and C-terminal (bottom) PHD recognition motifs found in HIF1&#945;, HIF2&#945; and DGK&#953;. The LxxLAP consensus motif is underlined, with the target prolyl residue in bold.</p></caption><graphic xlink:href="gkm932f3"/></fig>
###xml 862 871 836 845 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 946 947 917 918 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 1169 1170 1137 1138 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 1376 1377 1334 1335 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
###xml 871 1716 845 1665 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42">Two-hybrid interaction between pVHL and the candidate substrate, DGK&#953;. (<bold>a</bold>) Schematic representation of full-length DGK&#953; and the constructs used in two-hybrid assays. Key domains and sequence motifs are indicated at the top, and the two LxxLAP motifs are indicated at the bottom of the bars. (<bold>b</bold>) ELB-, ELC- and LxxLAP motif-dependent interaction between pVHL and DGK&#953;. Two-hybrid interactions between BD-pVHL and the indicated AD-DGK&#953; and AD-HIF1&#945; constructs were assayed as in Figure 2a. (<bold>c</bold>) Expression levels of AD-DGK&#953; constructs. Protein samples were prepared as in Figure 2b&#8211;f. Shown are representative samples taken from CG1945BC cells expressing the indicated DGK&#953; constructs. Expression levels were determined by western blot (WB) using Gal4-AD antibody. Asterisks indicate bands of the different DGK&#953; constructs.</p>
###xml 871 1716 845 1665 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="42">Two-hybrid interaction between pVHL and the candidate substrate, DGK&#953;. (<bold>a</bold>) Schematic representation of full-length DGK&#953; and the constructs used in two-hybrid assays. Key domains and sequence motifs are indicated at the top, and the two LxxLAP motifs are indicated at the bottom of the bars. (<bold>b</bold>) ELB-, ELC- and LxxLAP motif-dependent interaction between pVHL and DGK&#953;. Two-hybrid interactions between BD-pVHL and the indicated AD-DGK&#953; and AD-HIF1&#945; constructs were assayed as in Figure 2a. (<bold>c</bold>) Expression levels of AD-DGK&#953; constructs. Protein samples were prepared as in Figure 2b&#8211;f. Shown are representative samples taken from CG1945BC cells expressing the indicated DGK&#953; constructs. Expression levels were determined by western blot (WB) using Gal4-AD antibody. Asterisks indicate bands of the different DGK&#953; constructs.</p></caption>
###xml 1716 1716 1665 1665 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm932f4"/>
###xml 862 1716 836 1665 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="42">Two-hybrid interaction between pVHL and the candidate substrate, DGK&#953;. (<bold>a</bold>) Schematic representation of full-length DGK&#953; and the constructs used in two-hybrid assays. Key domains and sequence motifs are indicated at the top, and the two LxxLAP motifs are indicated at the bottom of the bars. (<bold>b</bold>) ELB-, ELC- and LxxLAP motif-dependent interaction between pVHL and DGK&#953;. Two-hybrid interactions between BD-pVHL and the indicated AD-DGK&#953; and AD-HIF1&#945; constructs were assayed as in Figure 2a. (<bold>c</bold>) Expression levels of AD-DGK&#953; constructs. Protein samples were prepared as in Figure 2b&#8211;f. Shown are representative samples taken from CG1945BC cells expressing the indicated DGK&#953; constructs. Expression levels were determined by western blot (WB) using Gal4-AD antibody. Asterisks indicate bands of the different DGK&#953; constructs.</p></caption><graphic xlink:href="gkm932f4"/></fig>
A particularly interesting new interactor is diacylglycerolkinase iota (DGKiota), a member of an enzyme family involved in the regulation of intracellular diacylglycerol and phosphatidic acid levels (20,34). DGKiota is predominantly expressed in brain and retina, two tissues that are most frequently affected in VHL disease. Intriguingly, DGKiota contains two LxxLAP motifs at residues Pro147 and Pro903 that are potential targets for PHD-catalyzed prolyl hydroxylation (Figure 3), one of which was present in the original isolate from the two-hybrid screen (DGKiota668-1065; Figure 4a and Table 2). Figure 3.DGKiota possesses two LxxLAP motifs. Sequence alignments of the N-terminal (top) and C-terminal (bottom) PHD recognition motifs found in HIF1alpha, HIF2alpha and DGKiota. The LxxLAP consensus motif is underlined, with the target prolyl residue in bold.Figure 4.Two-hybrid interaction between pVHL and the candidate substrate, DGKiota. (a) Schematic representation of full-length DGKiota and the constructs used in two-hybrid assays. Key domains and sequence motifs are indicated at the top, and the two LxxLAP motifs are indicated at the bottom of the bars. (b) ELB-, ELC- and LxxLAP motif-dependent interaction between pVHL and DGKiota. Two-hybrid interactions between BD-pVHL and the indicated AD-DGKiota and AD-HIF1alpha constructs were assayed as in Figure 2a. (c) Expression levels of AD-DGKiota constructs. Protein samples were prepared as in Figure 2b-f. Shown are representative samples taken from CG1945BC cells expressing the indicated DGKiota constructs. Expression levels were determined by western blot (WB) using Gal4-AD antibody. Asterisks indicate bands of the different DGKiota constructs.
###end p 40
###begin p 41
DGKiota possesses two LxxLAP motifs. Sequence alignments of the N-terminal (top) and C-terminal (bottom) PHD recognition motifs found in HIF1alpha, HIF2alpha and DGKiota. The LxxLAP consensus motif is underlined, with the target prolyl residue in bold.
###end p 41
###begin p 42
###xml 75 76 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 298 299 292 293 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 505 506 489 490 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</bold>
Two-hybrid interaction between pVHL and the candidate substrate, DGKiota. (a) Schematic representation of full-length DGKiota and the constructs used in two-hybrid assays. Key domains and sequence motifs are indicated at the top, and the two LxxLAP motifs are indicated at the bottom of the bars. (b) ELB-, ELC- and LxxLAP motif-dependent interaction between pVHL and DGKiota. Two-hybrid interactions between BD-pVHL and the indicated AD-DGKiota and AD-HIF1alpha constructs were assayed as in Figure 2a. (c) Expression levels of AD-DGKiota constructs. Protein samples were prepared as in Figure 2b-f. Shown are representative samples taken from CG1945BC cells expressing the indicated DGKiota constructs. Expression levels were determined by western blot (WB) using Gal4-AD antibody. Asterisks indicate bands of the different DGKiota constructs.
###end p 42
###begin p 43
###xml 203 211 197 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 309 317 300 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 925 933 904 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1192 1200 1171 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1441 1449 1417 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1599 1601 1575 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1604 1613 1580 1589 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1613 1819 1589 1789 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="44">PHD3-dependent two-hybrid interaction between pVHL and DGK&#953;. Two-hybrid interactions between BD-pVHL and AD-DGK&#953; in the absence and presence of the indicated PHD isoforms were assayed as in Figure 2a.</p>
###xml 1613 1819 1589 1789 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="44">PHD3-dependent two-hybrid interaction between pVHL and DGK&#953;. Two-hybrid interactions between BD-pVHL and AD-DGK&#953; in the absence and presence of the indicated PHD isoforms were assayed as in Figure 2a.</p></caption>
###xml 1819 1819 1789 1789 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm932f5"/>
###xml 1604 1819 1580 1789 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="44">PHD3-dependent two-hybrid interaction between pVHL and DGK&#953;. Two-hybrid interactions between BD-pVHL and AD-DGK&#953; in the absence and presence of the indicated PHD isoforms were assayed as in Figure 2a.</p></caption><graphic xlink:href="gkm932f5"/></fig>
We thus further characterized the two-hybrid interaction between DGKiota and pVHL. To map the region of pVHL binding more precisely, we generated different truncated versions of DGKiota fused to the AD (Figure 4a). While full-length DGKiota1-1065 interacted with pVHL in a PHD3- and ELB/ELC-dependent manner (Figure 4b), C-terminally truncated variants lacking the LxxLAP motif at Pro903 failed to interact, demonstrating that the C-terminal LxxLAP motif is required for the interaction with pVHL. Consistently, the C-terminal fragment DGKiota879-1065 including the C-terminal LxxLAP motif was sufficient for the pVHL interaction. Next, we directly tested the importance of the LxxLAP motif for pVHL interaction by mutating the critical prolyl residue, either alone (DGKiota879-1065PA) or in concert with the N-terminal LxxLAP motif (DGKiota1-1065PPAA). Importantly, neither of the two DGKiota variants interacted with pVHL (Figure 4b), strongly suggesting that the two-hybrid interaction depends on the PHD3-catalyzed prolyl hydroxylation of residue Pro903. The expression levels of these mutant prey constructs were found to be very similar to those of the respective wild-type constructs (Figure 4c). Furthermore, we analyzed the PHD specificity of the interaction and found that full-length DGKiota interacted strongly with pVHL in the presence of PHD3, while only a very weak interaction was detectable in the presence of PHD1 or PHD2 (Figure 5). This result is consistent with the possibility that PHD3 has evolved to recognize a broader range of substrates than the PHD1 and PHD2 isoenzymes (32). Figure 5.PHD3-dependent two-hybrid interaction between pVHL and DGKiota. Two-hybrid interactions between BD-pVHL and AD-DGKiota in the absence and presence of the indicated PHD isoforms were assayed as in Figure 2a.
###end p 43
###begin p 44
PHD3-dependent two-hybrid interaction between pVHL and DGKiota. Two-hybrid interactions between BD-pVHL and AD-DGKiota in the absence and presence of the indicated PHD isoforms were assayed as in Figure 2a.
###end p 44
###begin p 45
###xml 366 374 357 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 534 543 522 531 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 543 1021 531 997 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="46">pVHL and DGK&#953; interact in human cells. Lysates (Input) of human 293T cells overexpressing HA-tagged DGK&#953; in the absence (&#8211;) or presence of the indicated FLAG-tagged pVHL isoform were subjected to immunoprecipitation using anti-FLAG antibody (IP: FLAG). Immunoprecipitated pVHL and DGK&#953; were detected by western blot (WB) using anti-FLAG and anti-DGK&#953; antibodies as indicated. The asterisk marks the light chain of the anti-FLAG antibody used for immunoprecipitation.</p>
###xml 543 1021 531 997 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="46">pVHL and DGK&#953; interact in human cells. Lysates (Input) of human 293T cells overexpressing HA-tagged DGK&#953; in the absence (&#8211;) or presence of the indicated FLAG-tagged pVHL isoform were subjected to immunoprecipitation using anti-FLAG antibody (IP: FLAG). Immunoprecipitated pVHL and DGK&#953; were detected by western blot (WB) using anti-FLAG and anti-DGK&#953; antibodies as indicated. The asterisk marks the light chain of the anti-FLAG antibody used for immunoprecipitation.</p></caption>
###xml 1021 1021 997 997 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm932f6"/>
###xml 534 1021 522 997 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="46">pVHL and DGK&#953; interact in human cells. Lysates (Input) of human 293T cells overexpressing HA-tagged DGK&#953; in the absence (&#8211;) or presence of the indicated FLAG-tagged pVHL isoform were subjected to immunoprecipitation using anti-FLAG antibody (IP: FLAG). Immunoprecipitated pVHL and DGK&#953; were detected by western blot (WB) using anti-FLAG and anti-DGK&#953; antibodies as indicated. The asterisk marks the light chain of the anti-FLAG antibody used for immunoprecipitation.</p></caption><graphic xlink:href="gkm932f6"/></fig>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 458 463 <span type="species:ncbi:9606">human</span>
###xml 572 577 <span type="species:ncbi:9606">human</span>
###xml 604 609 <span type="species:ncbi:9606">human</span>
Finally, we wished to test whether pVHL and DGKiota also interact in human cells. To this end, 293T cells were transiently transfected with expression plasmids for full-length DGKiota and the long and short isoforms of pVHL, respectively. DGKiota was efficiently co-immunoprecipitated with both pVHL isoforms, but not in the negative control lacking exogenous pVHL (Figure 6). Thus, the novel two-hybrid interactor DGKiota physically associates with pVHL in human cells, further strengthening the validity of our two-hybrid approach. Figure 6.pVHL and DGKiota interact in human cells. Lysates (Input) of human 293T cells overexpressing HA-tagged DGKiota in the absence (-) or presence of the indicated FLAG-tagged pVHL isoform were subjected to immunoprecipitation using anti-FLAG antibody (IP: FLAG). Immunoprecipitated pVHL and DGKiota were detected by western blot (WB) using anti-FLAG and anti-DGKiota antibodies as indicated. The asterisk marks the light chain of the anti-FLAG antibody used for immunoprecipitation.
###end p 45
###begin p 46
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
pVHL and DGKiota interact in human cells. Lysates (Input) of human 293T cells overexpressing HA-tagged DGKiota in the absence (-) or presence of the indicated FLAG-tagged pVHL isoform were subjected to immunoprecipitation using anti-FLAG antibody (IP: FLAG). Immunoprecipitated pVHL and DGKiota were detected by western blot (WB) using anti-FLAG and anti-DGKiota antibodies as indicated. The asterisk marks the light chain of the anti-FLAG antibody used for immunoprecipitation.
###end p 46
###begin title 47
DISCUSSION
###end title 47
###begin p 48
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</italic>
###xml 192 197 192 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35 B36 B37">35&#8211;37</xref>
###xml 273 276 273 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 486 489 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
Mutations in the von Hippel-Lindau tumor suppressor gene (VHL) are the basis of the familial tumor syndrome von Hippel-Lindau disease and the majority of sporadic renal clear cell carcinomas (35-37). Mutational inactivation of pVHL, the substrate-binding subunit of the CBCVHL ubiquitin ligase complex, leads to the constitutive stabilization of the key cellular substrate, HIF1/2alpha, and presumably other cellular targets. However, systematic approaches for the identification of CBCVHL substrates have so far been largely unsuccessful, despite the great medical relevance.
###end p 48
###begin p 49
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1640 1642 1628 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1643 1648 1631 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38 B39 B40">38&#8211;40</xref>
###xml 1752 1759 1740 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 215 220 <span type="species:ncbi:4932">yeast</span>
###xml 471 476 <span type="species:ncbi:4932">yeast</span>
We have designed and established a powerful adaptation of the Y2H system that allows to screen for novel targets of the pVHL tumor suppressor protein. Our strategy relies on the reconstitution of the VCB complex in yeast (19), which enables pVHL to adopt its native 3D conformation, and on the coexpression of the substrate modifying enzymes of the PHD family. In a novel combination, our system introduces both a new enzymatic activity and structural cofactors into the yeast background to screen for protein-protein interactions requiring a complex interplay of post-translational modification and physical interaction. This combination allows for the rigorous testing of positive clones by omitting either the enzymatic activity or the cofactors. Our strategy is not only useful in order to eliminate a large number of false-positive interactors resulting from interaction with non-native bait, but also, more importantly, enables for the first time to distinguish between potential substrates and regulatory or scaffolding proteins. This is illustrated by our proof-of-principle library screen, which identified the known pVHL substrates HIF1/2alpha as strictly PHD-dependent interactors. To our knowledge, this is the first identification of HIF1/2alpha in a Y2H screen and, in fact, in any approach aiming at the identification of pVHL substrates. Previous standard Y2H screens in the absence of ELB, ELC and PHDs had not only failed to identify HIF1/2alpha, but also often led to the isolation of molecular chaperones and enzymes of the protein degradation machinery, suggesting that most of these proteins bound to non-native pVHL (27,38-40). Of note, we did not identify any chaperone or notorious false-positive Y2H interactor in our screen (Table 2), underlining its superior design with respect to the integrity of the native 3D structure of pVHL. Together, our results demonstrate that our adaptation of the Y2H system can successfully be used to screen for pVHL substrates of even extremely low cellular abundance such as HIF1/2alpha, as long as their transcripts are represented in a cDNA library. This is a significant advantage over proteomics strategies based on affinity purification, which often fail to identify low abundance binding partners because of insufficient sensitivity of detection and/or high background from abundant proteins.
###end p 49
###begin p 50
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 292 295 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 880 882 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 883 885 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 1409 1411 1409 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1546 1548 1546 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 1752 1754 1752 1754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1040 1045 <span type="species:ncbi:4932">yeast</span>
Our system sets the precedence for a method that can easily be adapted to other heterooligomeric ubiquitin ligases, in particular cullin-based complexes with their diverse substrate recognition requirements (3). Prime examples of high medical importance are Cullin-5 complexes which, like CBCVHL, contain ELB and ELC as core subunits, but use members from the SOCS (suppressor of cytokine signaling) box superfamily as substrate-binding subunits (3,41,42). Some SOCS box proteins like CIS-1, SOCS-1, SOCS-2 and SOCS-3 recruit phosphotyrosine-modified substrates via SH2 domains and are important regulators of immune responses and other cytokine-regulated processes (43). Remarkably, these SOCS proteins exhibit high substrate specificity despite similarities in the composition of their SH2 domains (44), and regions outside the SH2 domains also contribute to substrate binding (45,46). Replacing the bait vector of our system with one that encodes SOCS proteins as baits together with the critical tyrosine kinases (which are absent from yeast) should be a straightforward adaptation to study the exact binding requirements of SOCS proteins and to screen for novel substrates. SOCS proteins with other functional domains are less well understood, but recent findings suggest that an ankyrin domain-containing family member, ASB4, is modified by an asparagine hydroxylase called FIH (factor inhibiting HIF) (47), an oxygen-converting enzyme related to the PHDs which was first identified as a negative regulator of HIF transcriptional activity (48). ASB4 plays an important role in vascular differentiation and has been proposed to recruit yet unknown substrates to a Cullin-5 ubiquitin ligase complex in an asparagine hydroxylation-dependent manner (47). Consequently, employing a bait vector encoding ASB4 as bait together with FIH in our Y2H system could proof a successful adaptation to screen for ASB4 substrates.
###end p 50
###begin p 51
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</sup>
###xml 228 235 224 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 654 656 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
Our Y2H screen led to the identification of several potential novel CBCVHL substrates that showed a dependency on PHD and ELB/ELC, some containing an LxxLAP motif for recognition by PHDs similar to the one found in HIF1/2alpha (Table 2). One such candidate exhibiting interaction characteristics resembling those of HIF1/2alpha is DGKiota. We showed that the Y2H interaction between pVHL and DGKiota requires its C-terminal LxxLAP motif, which is not conserved among other DGK isoforms. Intriguingly, and in contrast to other DGK isoforms, which show a rather broad tissue distribution, expression of DGKiota appears to be strongest in brain and retina (20), which are both frequently affected in pVHL disease. This correlation might hint to a medically relevant functional interaction between pVHL and DGKiota, a possibility that is currently addressed in our laboratory.
###end p 51
###begin p 52
###xml 608 609 594 595 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 740 745 <span type="species:ncbi:4932">yeast</span>
In addition to the identification of further pVHL targets in Y2H screens using various cDNA libraries, our system is well suited to perform detailed analyses of the physical interaction between pVHL and full-length HIF1/2alpha. This should be a welcome addition to the currently available experimental approaches, which are limited to qualitative pull-down experiments and quantitative, but laborious biochemical measurements. The possibility to evaluate the Y2H interaction between pVHL and HIF1/2alpha in liquid culture using colorimetric beta-galactosidase activity assays based on ortho-nitrophenyl-beta-d-galactopyranoside (ONPG) even provides the opportunity for semi-quantitative analyses. Additionally, since the PHDs are active in yeast, their specificity and mechanism of HIF1/2alpha regulation could also be further characterized by mutational analysis, using the pVHL-HIF1/2alpha interaction as a functional read-out.
###end p 52
###begin p 53
###xml 182 183 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 184 186 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 187 189 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 953 955 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 1041 1043 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 1062 1064 1040 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1152 1154 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 1155 1157 1129 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
Further future applications of the system could include screens for therapeutically relevant chemical compounds that specifically alter the interaction between pVHL and HIF1/2alpha (4,49,50). For example, drugs that rescue or improve the binding of HIF1/2alpha to mutant pVHL could lead to improved down-regulation of HIF1/2alpha in patients carrying certain partial loss-of-function VHL alleles. Conversely, compounds interrupting the physiological interaction between pVHL and HIF1/2alpha that occurs under hypoxic conditions might be useful in the treatment of acute ischemia. Such compounds may conveniently be screened for in liquid culture high-throughput formats using ONPG beta-galactosidase activity assays. In the past, Y2H-based approaches have successfully been used to identify small-molecule inhibitors of protein-protein interactions, for example a modulator of neuronal N-type calcium channels from a library of 156 000 small molecules (51), and an inhibitor of TGFbeta receptor signaling from a library of 23 000 compounds (52). We found that Co2+, a known inhibitor of the interaction between pVHL and HIF1/2alpha in mammalian cells (53,54), is also effective in the context of our Y2H system (Supplementary Figure S1), which further underlines the feasibility of small molecule screens using this system.
###end p 53
###begin title 54
SUPPLEMENTARY DATA
###end title 54
###begin p 55
Supplementary Data are available at NAR Online.
###end p 55
###begin title 56
Supplementary Material
###end title 56
###begin title 57
[Supplementary Data]
###end title 57
###begin title 58
ACKNOWLEDGEMENTS
###end title 58
###begin p 59
We thank Stefan Jentsch for continued support; Richard Klausner, Peter Ratcliffe, Steven McKnight and Steven Prescott for materials; Stefan Muller and Christian Schuberth for critical reading of the manuscript. This work was supported by Emmy Noether grant Bu 951/1-3 and/1-4 of the Deutsche Forschungsgemeinschaft to A.B. Funding to pay the Open Access publication charges for this article was provided by the Deutsche Forschungsgemeinschaft.
###end p 59
###begin p 60
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 60
###begin title 61
REFERENCES
###end title 61
###begin article-title 62
Analyzing protein-protein interactions using two-hybrid system
###end article-title 62
###begin article-title 63
High-throughput screening for protein-protein interactions using two-hybrid assay
###end article-title 63
###begin article-title 64
Function and regulation of cullin-RING ubiquitin ligases
###end article-title 64
###begin article-title 65
Targeting HIF-1 for cancer therapy
###end article-title 65
###begin article-title 66
Regulation of angiogenesis by hypoxia: role of the HIF system
###end article-title 66
###begin article-title 67
HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs
###end article-title 67
###begin article-title 68
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. elegans</italic>
###xml 0 10 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
###end article-title 68
###begin article-title 69
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
###end article-title 69
###begin article-title 70
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing
###end article-title 70
###begin article-title 71
A conserved family of prolyl-4-hydroxylases that modify HIF
###end article-title 71
###begin article-title 72
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
###end article-title 72
###begin article-title 73
The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma
###end article-title 73
###begin article-title 74
Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo
###end article-title 74
###begin article-title 75
Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function
###end article-title 75
###begin article-title 76
The von Hippel-Lindau tumor suppressor protein is a molten globule under native conditions: implications for its physiological activities
###end article-title 76
###begin article-title 77
Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions
###end article-title 77
###begin article-title 78
Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling
###end article-title 78
###begin article-title 79
Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL
###end article-title 79
###begin article-title 80
###xml 46 51 <span type="species:ncbi:4932">yeast</span>
Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein
###end article-title 80
###begin article-title 81
###xml 44 49 <span type="species:ncbi:9606">human</span>
The cloning and characterization of a novel human diacylglycerol kinase, DGKiota
###end article-title 81
###begin article-title 82
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
Epitope tagging of yeast genes using a PCR-based strategy: more tags and improved practical routines
###end article-title 82
###begin article-title 83
###xml 18 23 <span type="species:ncbi:4932">yeast</span>
Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method
###end article-title 83
###begin article-title 84
###xml 29 34 <span type="species:ncbi:9606">human</span>
Role of VHL gene mutation in human cancer
###end article-title 84
###begin article-title 85
###xml 75 79 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
The VHL tumor suppressor in development and disease: functional studies in mice by conditional gene targeting
###end article-title 85
###begin article-title 86
Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer
###end article-title 86
###begin article-title 87
Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL
###end article-title 87
###begin article-title 88
The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity
###end article-title 88
###begin article-title 89
pVHL and GSK3beta are components of a primary cilium-maintenance signalling network
###end article-title 89
###begin article-title 90
HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia
###end article-title 90
###begin article-title 91
Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
###end article-title 91
###begin article-title 92
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF
###end article-title 92
###begin article-title 93
Many amino acid substitutions in a hypoxia-inducible transcription factor (HIF)-1alpha-like peptide cause only minor changes in its hydroxylation by the HIF prolyl 4-hydroxylases: substitution of 3,4-dehydroproline or azetidine-2-carboxylic acid for the proline leads to a high rate of uncoupled 2-oxoglutarate decarboxylation
###end article-title 93
###begin article-title 94
###xml 30 35 <span type="species:ncbi:9606">human</span>
Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing
###end article-title 94
###begin article-title 95
Signaling roles of diacylglycerol kinases
###end article-title 95
###begin article-title 96
von Hippel-Lindau disease
###end article-title 96
###begin article-title 97
The VHL tumour-suppressor gene paradigm
###end article-title 97
###begin article-title 98
von Hippel-Lindau disease
###end article-title 98
###begin article-title 99
Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product
###end article-title 99
###begin article-title 100
Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein
###end article-title 100
###begin article-title 101
Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein
###end article-title 101
###begin article-title 102
VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases
###end article-title 102
###begin article-title 103
The SOCS box: a tale of destruction and degradation
###end article-title 103
###begin article-title 104
The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response
###end article-title 104
###begin article-title 105
The SH2 domain: versatile signaling module and pharmaceutical target
###end article-title 105
###begin article-title 106
Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction
###end article-title 106
###begin article-title 107
The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability
###end article-title 107
###begin article-title 108
ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism
###end article-title 108
###begin article-title 109
Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch
###end article-title 109
###begin article-title 110
HIF-1 as a target for drug development
###end article-title 110
###begin article-title 111
The HIF pathway as a therapeutic target
###end article-title 111
###begin article-title 112
###xml 70 75 <span type="species:ncbi:4932">yeast</span>
Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen
###end article-title 112
###begin article-title 113
Identification of protein interaction antagonists using the repressed transactivator two-hybrid system
###end article-title 113
###begin article-title 114
Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha
###end article-title 114
###begin article-title 115
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
###end article-title 115

